Subcutaneous Infusion Systems Market Report

Europe Subcutaneous Infusion Systems Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 16, 2019
  • PAGES：151
  • REPORT CODE：GMM325499
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Subcutaneous Infusion Systems market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 11.0% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Subcutaneous Infusion Systems Market Segmentations:

    By Player:

    • Baxter

    • NeuroDerm

    • US Worldmeds

    • Capricor

    • SteadyMed

    • Octapharma

    • CSL Behring

    • UCB

    • Amgen

    • AstraZeneca

    • United Therapeutics

    • Rhythm Metabolic

    • Roche

    • ScPharmceuticals

    • Grifols

    • GlaxoSmithKline

    • Ferring

    • Britannia

    • Takeda

    • Janssen

    By Type:

    • General subcutaneous infusion system

    • Continuous Subcutaneous Insulin Infusion (Insulin Pump)

    • Others

    By End-User:

    • Medical care

    • Hospital

    • Others

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Subcutaneous Infusion Systems Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of General subcutaneous infusion system from 2014 to 2026

    • 1.3.2 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Continuous Subcutaneous Insulin Infusion (Insulin Pump) from 2014 to 2026

    • 1.3.3 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Medical care from 2014 to 2026

    • 1.4.2 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.3 Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Others from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Subcutaneous Infusion Systems Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Subcutaneous Infusion Systems by Major Types

      • 3.4.1 Market Size and Growth Rate of General subcutaneous infusion system

      • 3.4.2 Market Size and Growth Rate of Continuous Subcutaneous Insulin Infusion (Insulin Pump)

      • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Subcutaneous Infusion Systems Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Subcutaneous Infusion Systems by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Subcutaneous Infusion Systems for Medical care

      • 4.4.2 Market Size and Growth Rate of Subcutaneous Infusion Systems for Hospital

      • 4.4.3 Market Size and Growth Rate of Subcutaneous Infusion Systems for Others

    5 Market Analysis by Major Regions

    • 5.1 Europe Subcutaneous Infusion Systems Production Analysis by Top Regions

    • 5.2 Europe Subcutaneous Infusion Systems Consumption Analysis by Top Regions

    • 5.3 Europe Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.3 France Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    6 Product Circulation of Subcutaneous Infusion Systems Market among Top Countries

    • 6.1 Top 5 Export Countries in Subcutaneous Infusion Systems Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Subcutaneous Infusion Systems Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Subcutaneous Infusion Systems Landscape Analysis

    • 7.1 Germany Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 7.2 Germany Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    8. UK Subcutaneous Infusion Systems Landscape Analysis

    • 8.1 UK Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 8.2 UK Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    9. France Subcutaneous Infusion Systems Landscape Analysis

    • 9.1 France Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 9.2 France Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    10. Italy Subcutaneous Infusion Systems Landscape Analysis

    • 10.1 Italy Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 10.2 Italy Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    11. Spain Subcutaneous Infusion Systems Landscape Analysis

    • 11.1 Spain Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 11.2 Spain Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    12. Poland Subcutaneous Infusion Systems Landscape Analysis

    • 12.1 Poland Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 12.2 Poland Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    13. Russia Subcutaneous Infusion Systems Landscape Analysis

    • 13.1 Russia Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 13.2 Russia Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    14. Switzerland Subcutaneous Infusion Systems Landscape Analysis

    • 14.1 Switzerland Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 14.2 Switzerland Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    15. Turkey Subcutaneous Infusion Systems Landscape Analysis

    • 15.1 Turkey Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 15.2 Turkey Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Landscape Analysis by Top Countries

      • 16.3.1 Denmark Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 16.3.2 Finland Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 16.3.3 Norway Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 16.3.4 Sweden Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 16.3.6 Iceland Subcutaneous Infusion Systems Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Landscape Analysis by Top Countries

      • 17.3.1 Belgium Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 17.3.2 Netherlands Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 17.3.3 Luxembourg Subcutaneous Infusion Systems Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Landscape Analysis by Top Countries

      • 18.3.1 Estonia Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 18.3.2 Latvia Subcutaneous Infusion Systems Market Volume and Growth Rate

      • 18.3.3 Lithuania Subcutaneous Infusion Systems Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Baxter

      • 19.1.1 Baxter Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 NeuroDerm

      • 19.2.1 NeuroDerm Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 US Worldmeds

      • 19.3.1 US Worldmeds Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 Capricor

      • 19.4.1 Capricor Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 SteadyMed

      • 19.5.1 SteadyMed Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Octapharma

      • 19.6.1 Octapharma Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 CSL Behring

      • 19.7.1 CSL Behring Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 UCB

      • 19.8.1 UCB Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Amgen

      • 19.9.1 Amgen Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 AstraZeneca

      • 19.10.1 AstraZeneca Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    • 19.11 United Therapeutics

      • 19.11.1 United Therapeutics Company Profile and Development Status

      • 19.11.2 Market Performance

      • 19.11.3 Product and Service Introduction

    • 19.12 Rhythm Metabolic

      • 19.12.1 Rhythm Metabolic Company Profile and Development Status

      • 19.12.2 Market Performance

      • 19.12.3 Product and Service Introduction

    • 19.13 Roche

      • 19.13.1 Roche Company Profile and Development Status

      • 19.13.2 Market Performance

      • 19.13.3 Product and Service Introduction

    • 19.14 ScPharmceuticals

      • 19.14.1 ScPharmceuticals Company Profile and Development Status

      • 19.14.2 Market Performance

      • 19.14.3 Product and Service Introduction

    • 19.15 Grifols

      • 19.15.1 Grifols Company Profile and Development Status

      • 19.15.2 Market Performance

      • 19.15.3 Product and Service Introduction

    • 19.16 GlaxoSmithKline

      • 19.16.1 GlaxoSmithKline Company Profile and Development Status

      • 19.16.2 Market Performance

      • 19.16.3 Product and Service Introduction

    • 19.17 Ferring

      • 19.17.1 Ferring Company Profile and Development Status

      • 19.17.2 Market Performance

      • 19.17.3 Product and Service Introduction

    • 19.18 Britannia

      • 19.18.1 Britannia Company Profile and Development Status

      • 19.18.2 Market Performance

      • 19.18.3 Product and Service Introduction

    • 19.19 Takeda

      • 19.19.1 Takeda Company Profile and Development Status

      • 19.19.2 Market Performance

      • 19.19.3 Product and Service Introduction

    • 19.20 Janssen

      • 19.20.1 Janssen Company Profile and Development Status

      • 19.20.2 Market Performance

      • 19.20.3 Product and Service Introduction

    The List of Tables and Figures (Totals 84 Figures and 132 Tables)

    • Figure Product Picture

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of General subcutaneous infusion system from 2014 to 2026

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Continuous Subcutaneous Insulin Infusion (Insulin Pump) from 2014 to 2026

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Medical care from 2014 to 2026

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Subcutaneous Infusion Systems Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Germany Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure UK Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure France Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Subcutaneous Infusion Systems Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Subcutaneous Infusion Systems Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Subcutaneous Infusion Systems

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Subcutaneous Infusion Systems by Different Types from 2014 to 2026

    • Table Consumption Share of Subcutaneous Infusion Systems by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of General subcutaneous infusion system

    • Figure Market Size and Growth Rate of Continuous Subcutaneous Insulin Infusion (Insulin Pump)

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Subcutaneous Infusion Systems by Different End-Users from 2014 to 2026

    • Table Consumption Share of Subcutaneous Infusion Systems by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Medical care

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Others

    • Table Europe Subcutaneous Infusion Systems Production by Major Regions

    • Table Europe Subcutaneous Infusion Systems Production Share by Major Regions

    • Figure Europe Subcutaneous Infusion Systems Production Share by Major Countries and Regions in 2014

    • Table Europe Subcutaneous Infusion Systems Consumption by Major Regions

    • Table Europe Subcutaneous Infusion Systems Consumption Share by Major Regions

    • Table Germany Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table UK Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table France Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Italy Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Spain Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Poland Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Russia Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Switzerland Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Turkey Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Subcutaneous Infusion Systems Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Germany Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Germany Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Germany Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table UK Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table UK Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table UK Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table UK Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table France Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table France Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table France Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table France Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Italy Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Italy Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Italy Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Italy Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Spain Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Spain Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Spain Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Spain Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Poland Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Poland Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Poland Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Poland Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Russia Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Russia Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Russia Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Russia Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Switzerland Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Switzerland Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Switzerland Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Turkey Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Turkey Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Turkey Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Subcutaneous Infusion Systems Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Subcutaneous Infusion Systems Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Subcutaneous Infusion Systems Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Subcutaneous Infusion Systems Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Baxter

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter

    • Figure Sales and Growth Rate Analysis of Baxter

    • Figure Revenue and Market Share Analysis of Baxter

    • Table Product and Service Introduction of Baxter

    • Table Company Profile and Development Status of NeuroDerm

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of NeuroDerm

    • Figure Sales and Growth Rate Analysis of NeuroDerm

    • Figure Revenue and Market Share Analysis of NeuroDerm

    • Table Product and Service Introduction of NeuroDerm

    • Table Company Profile and Development Status of US Worldmeds

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of US Worldmeds

    • Figure Sales and Growth Rate Analysis of US Worldmeds

    • Figure Revenue and Market Share Analysis of US Worldmeds

    • Table Product and Service Introduction of US Worldmeds

    • Table Company Profile and Development Status of Capricor

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Capricor

    • Figure Sales and Growth Rate Analysis of Capricor

    • Figure Revenue and Market Share Analysis of Capricor

    • Table Product and Service Introduction of Capricor

    • Table Company Profile and Development Status of SteadyMed

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SteadyMed

    • Figure Sales and Growth Rate Analysis of SteadyMed

    • Figure Revenue and Market Share Analysis of SteadyMed

    • Table Product and Service Introduction of SteadyMed

    • Table Company Profile and Development Status of Octapharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma

    • Figure Sales and Growth Rate Analysis of Octapharma

    • Figure Revenue and Market Share Analysis of Octapharma

    • Table Product and Service Introduction of Octapharma

    • Table Company Profile and Development Status of CSL Behring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring

    • Figure Sales and Growth Rate Analysis of CSL Behring

    • Figure Revenue and Market Share Analysis of CSL Behring

    • Table Product and Service Introduction of CSL Behring

    • Table Company Profile and Development Status of UCB

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of UCB

    • Figure Sales and Growth Rate Analysis of UCB

    • Figure Revenue and Market Share Analysis of UCB

    • Table Product and Service Introduction of UCB

    • Table Company Profile and Development Status of Amgen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen

    • Figure Sales and Growth Rate Analysis of Amgen

    • Figure Revenue and Market Share Analysis of Amgen

    • Table Product and Service Introduction of Amgen

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of United Therapeutics

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of United Therapeutics

    • Figure Sales and Growth Rate Analysis of United Therapeutics

    • Figure Revenue and Market Share Analysis of United Therapeutics

    • Table Product and Service Introduction of United Therapeutics

    • Table Company Profile and Development Status of Rhythm Metabolic

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Rhythm Metabolic

    • Figure Sales and Growth Rate Analysis of Rhythm Metabolic

    • Figure Revenue and Market Share Analysis of Rhythm Metabolic

    • Table Product and Service Introduction of Rhythm Metabolic

    • Table Company Profile and Development Status of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Company Profile and Development Status of ScPharmceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ScPharmceuticals

    • Figure Sales and Growth Rate Analysis of ScPharmceuticals

    • Figure Revenue and Market Share Analysis of ScPharmceuticals

    • Table Product and Service Introduction of ScPharmceuticals

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of Ferring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ferring

    • Figure Sales and Growth Rate Analysis of Ferring

    • Figure Revenue and Market Share Analysis of Ferring

    • Table Product and Service Introduction of Ferring

    • Table Company Profile and Development Status of Britannia

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Britannia

    • Figure Sales and Growth Rate Analysis of Britannia

    • Figure Revenue and Market Share Analysis of Britannia

    • Table Product and Service Introduction of Britannia

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

    • Table Company Profile and Development Status of Janssen

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Janssen

    • Figure Sales and Growth Rate Analysis of Janssen

    • Figure Revenue and Market Share Analysis of Janssen

    • Table Product and Service Introduction of Janssen

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US